Loading market dashboard
Boston Scientific Corporation
BSXHealthcareNYSEUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Boston Scientific Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $30.59B | $30.11B - $31.55B | $6.68B | $5.195 | 12 |
| Dec 2029 | $28.05B | $27.61B - $28.93B | $6.12B | $4.736 | 12 |
| Dec 2028 | $25.28B | $25.27B - $25.29B | $5.52B | $4.153 | 25 |
| Dec 2027 | $23.36B | $22.84B - $24.41B | $5.10B | $3.73 | 23 |
| Dec 2026 | $21.63B | $21.47B - $21.89B | $4.72B | $3.366 | 22 |
| Dec 2025 | $20.07B | $20.05B - $20.12B | $4.38B | $3.036 | 21 |
| Dec 2024 | $16.61B | $16.54B - $16.68B | $3.63B | $2.465 | 19 |
| Dec 2023 | $15.23B | $14.99B - $15.70B | $3.32B | $1.246 | 12 |
| Dec 2022 | $12.68B | $12.55B - $13.06B | $2.65B | $1.735 | 10 |
| Dec 2021 | $11.87B | $11.75B - $12.23B | $2.31B | $1.613 | 11 |
| Dec 2020 | $10.03B | $9.93B - $10.33B | $2.12B | $1.045 | 11 |
| Dec 2019 | $10.74B | $10.63B - $11.06B | $1.16B | $1.568 | 10 |